Clinical Trial

NUclear MEdicine DIagnostic and Artificial Intelligence

Study acronym: NUMEDIA
Recruiting
View on ClinicalTrials.gov →
Summary
Artificial intelligence algorithms for parathyroid adenoma detection in parathyroid scans The aim of the study is to develop programs for the automatic subtraction of planar and tomographic parathyroid images and for the localization of parathyroid adenomas using artificial intelligence tools. Inclusion criteria Patients having undergone a double isotope parathyroid diagnostic examination using the standard Besançon University Hospital protocol (double injection of 123I and 99mTc, pinhole image, low energy high resolution (LEHR) and (single-photon emission tomography / Computed tomography) SPECT/CT +/- (positron emission tomography (PET) Choline). Secondary endpoints Concordance between diagnoses made by nuclear physicians using both methods (current method and new treatment method).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-07-25.
Status change: Not Yet Recruiting → Recruiting 2024-02-06
Trial Details
NCT Number NCT05963841
Lead Sponsor Centre Hospitalier Universitaire de Besancon
Collaborators: Franche-Comté Electronique Mécanique Thermique et Optique - Sciences et Technologies, UMR 6174
Conditions Hyperparathyroidism
Enrollment 1 participants
Start Date 2023-08-01
Primary Completion 2026-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2024-02-07